Nektar Therapeutics financial data

Symbol
NKTR on Nasdaq
Industry
Pharmaceutical Preparations
Location
455 Mission Bay Boulevard South, San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INHALE THERAPEUTIC SYSTEMS INC (to 1/10/2003), INHALE THERAPEUTIC SYSTEMS (to 5/14/1998)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 722 % -0.57%
Quick Ratio 33 % +38.7%
Debt-to-equity 182 % +87.1%
Return On Equity -115 % -2.07%
Return On Assets -40.6 % +28.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 184 M shares -2.97%
Common Stock, Shares, Outstanding 184 M shares -2.97%
Entity Public Float 109 M USD -84.5%
Common Stock, Value, Issued 19 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 195 M shares +3.11%
Weighted Average Number of Shares Outstanding, Diluted 195 M shares +3.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 90.2 M USD +1.51%
Research and Development Expense 111 M USD -21.5%
General and Administrative Expense 76.5 M USD -11.1%
Costs and Expenses 255 M USD -47.3%
Operating Income (Loss) -164 M USD +58.3%
Nonoperating Income (Expense) -11.6 M USD +33.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -176 M USD +57.3%
Income Tax Expense (Benefit) -172 K USD -106%
Net Income (Loss) Attributable to Parent -176 M USD +57.6%
Earnings Per Share, Basic -0.91 USD/shares +58.8%
Earnings Per Share, Diluted -0.91 USD/shares +58.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 48.6 M USD -36.8%
Accounts Receivable, after Allowance for Credit Loss, Current 3.62 M USD +20.8%
Inventory, Net 16.2 M USD -19.8%
Other Assets, Current 10.7 M USD -2.42%
Assets, Current 320 M USD -34.9%
Property, Plant and Equipment, Net 17.5 M USD -35.5%
Operating Lease, Right-of-Use Asset 17.3 M USD -59.1%
Goodwill 0 USD -100%
Other Assets, Noncurrent 4.66 M USD +231%
Assets 396 M USD -29.5%
Accounts Payable, Current 8.76 M USD +137%
Employee-related Liabilities, Current 7.38 M USD -50.4%
Accrued Liabilities, Current 24.3 M USD -35.1%
Liabilities, Current 52.4 M USD -12.5%
Operating Lease, Liability, Noncurrent 94.7 M USD -13.4%
Other Liabilities, Noncurrent 4.33 M USD -33.1%
Liabilities 269 M USD -16.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -403 K USD +92.9%
Retained Earnings (Accumulated Deficit) -3.51 B USD -5.27%
Stockholders' Equity Attributable to Parent 127 M USD -47.4%
Liabilities and Equity 396 M USD -29.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -47.9 M USD +7.76%
Net Cash Provided by (Used in) Financing Activities 42 M USD
Net Cash Provided by (Used in) Investing Activities 19.3 M USD -52.6%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 192 M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13.4 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48.6 M USD -36.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 855 M USD +4.69%
Deferred Tax Assets, Gross 859 M USD +3.7%
Operating Lease, Liability 118 M USD -10.4%
Payments to Acquire Property, Plant, and Equipment 157 K USD -63.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -171 M USD +58.8%
Lessee, Operating Lease, Liability, to be Paid 140 M USD -13%
Operating Lease, Liability, Current 19.4 M USD +3.17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.3 M USD +3.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.8 M USD +3.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -38 K USD +97.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.7 M USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23 M USD +3.16%
Deferred Tax Assets, Operating Loss Carryforwards 575 M USD +5.36%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) -60 K USD -112%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 126 M USD +47.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.7 M USD +3.15%
Operating Lease, Payments 21 M USD +4.48%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -43 K USD +92.9%
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 7 M USD -42.6%
Deferred Tax Assets, Net of Valuation Allowance 4.09 M USD -65.3%
Share-based Payment Arrangement, Expense 29.4 M USD -36.7%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%